Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia-Reference-Cited by-同舟云学术

Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia

Published:2023-09-06 Issue:1 Volume:13 Page:
ISSN:2044-5385
Container-title:Blood Cancer Journal
language:en
Short-container-title:Blood Cancer J.

Author:

Pitel Beth A.^ORCID,Zepeda-Mendoza Cinthya,Sachs Zohar^ORCID,Tang Hongwei,Shivaram Suganti,Sharma Neeraj^ORCID,Smadbeck James B.,Smoley Stephanie A.,Pearce Kathryn E.,Luoma Ivy M.,Cook Joselle^ORCID,Litzow Mark R.^ORCID,Hoppman Nicole L.,Viswanatha David,Xu Xinjie,Ketterling Rhett P.,Greipp Patricia T.^ORCID,Peterson Jess F.^ORCID,Baughn Linda B.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology

Link

https://www.nature.com/articles/s41408-023-00908-5.pdf

Reference15 articles.

1. Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic classification and prognosis in acute myeloid leukemia. N Engl J Med. 2016;374:2209–21.

2. Dohner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.

3. Duncavage EJ, Schroeder MC, O’Laughlin M, Wilson R, MacMillan S, Bohannon A, et al. Genome sequencing as an alternative to cytogenetic analysis in myeloid cancers. N Engl J Med. 2021;384:924–35.

4. Akkari YMN, Baughn LB, Dubuc AM, Smith AC, Mallo M, Dal Cin P, et al. Guiding the global evolution of cytogenetic testing for hematologic malignancies. Blood. 2022;139:2273–84.

5. Aypar U, Smoley SA, Pitel BA, Pearce KE, Zenka RM, Vasmatzis G, et al. Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia. Eur J Haematol. 2019;102:87–96.